C3Nano Refutes Cambrios’ Claims of Patent Invalidity

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
31
C3Nano Refutes Cambrios’ Claims of Patent Invalidity

HAYWARD, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) -- C3Nano Inc. , the world’s performance leader in transparent conductive inks and films used in flexible displays, touchscreens and other products refutes the claims made by China-based Cambrios in its attempt to initiate an inter partes review (IPR) related to the validity of one of C3Nano’s United States patents. Since inception in 2010, C3Nano has conducted R&D in the chemical fusing of conductive nanostructures , and is widely recognized by leading global customers as the first company to successfully develop a commercially viable and scalable transparent conductor based on nanoscale metallic fused conductors, with performance exceeding that of all other competitive technologies.  Cambrios is a subsidiary of CAM Holding Co., British Virgin Islands, a related party of TPK Holding Co., Ltd in China.

C3Nano has a large number of core patents protecting its commercial products including inks and films, as well as customers’ devices. The subject patent, number 9,183,968, is related to C3Nano’s unique technology based on fusing nanomaterials. 

“C3Nano will enforce its patents to protect its valuable proprietary technology, which has resulted in superior products,” said Cliff Morris, CEO of C3Nano.  “Preemptive attacks by Cambrios or other patent infringers will not thwart these efforts.” 

Background Recently, C3Nano has won several key business opportunities over Cambrios/CAM Holding Co. Ltd. and other competitors due to the superior performance of C3Nano products. C3Nano has observed increased media campaigns, including frivolous intellectual property claims, by competitors attempting to detract from C3Nano’s gain in worldwide market share.  It is well known in the industry that C3Nano’s unique and proprietary technology, NanoGlue™, is the critical enabler of the fusing of nanowires to alleviate junction resistance and create the superior performance needed for foldable devices and Tier 1 applications such as smart phones and tablets. The science and engineering behind NanoGlue have been validated globally by multiple customers as well as independent experts.

Cambrios, originally Cambrios Technologies Corporation, was an MIT spin-off that went into insolvency in 2016.  Public information indicates that over 80 million USD in equity had been invested and possibly lost by multiple U.S. and international investors. The company was liquidated with the assets auctioned off and purchased by Champ Great International Corporation, an entity whose name veils its connection to TPK Holding Co., Ltd. in China.

As a reincarnated Cambrios tries to restart its business under new Chinese ownership and management, it has sought quick monetization of the patents acquired from the defunct U.S. company. In comparison, C3Nano has benefited from stable management and R&D talent to advance its technology multiple generations ahead of competitors, and has industriously focused on commercialization of its technology to deliver the best performance and value to customers. 

Recent patent-related action by Cambrios represents ongoing fallout from the May 2018  Society for Information Display (SID) conference in Los Angeles, when Cambrios’ lead scientist presented data that raised questions among industry players of Cambrios’ possible infringement of C3Nano’s fusing IP. 

C3Nano began as a four-person startup, spun off from Stanford University. C3Nano is well known in the industry for its high ethical standards, respect of IP, and research and development philosophy that do not violate any known valid IP. C3Nano has strong customer loyalty because of its leading product performance and technical support. C3Nano will enforce its patents to protect its valuable proprietary technology and superior products. 

About C3Nano, Inc.

Founded in 2010 as a spinout from Stanford University, C3Nano is an advanced materials company focused on developing new materials and chemistries for a wide range of electronic applications. C3Nano’s investors and partners include GSR Ventures, Nissha Printing Co., Ltd., Phoenix Venture Partners, Hitachi Chemical, Lens Technology, Nagase America, and several undisclosed investors, including a top global mobile and internet technology company headquartered in Silicon Valley.

Contact Kevin Gallagher Gallagher PR +1 (510) 599-0416 kevin@gallagherpr.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...e26eca63c8

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 5

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Security: The Fast Guard App Revolution

Updated Category News Views 109

Transforming Security with the Fast Guard App Fast Guard Service, a prominent name in licensed security guard services, has introduced a cutting-edge solution for the construction and property management sectors. This newly enhanced Fast Guard App empowers users to swiftly order and manage essential security services, including fire watch and armed or unarmed guards,...

Continue Reading
Weak Demand and Global Issues Impact China's Industries

Updated Category Economy Views 428

China's Industrial Profits Accelerate in June China's industrial gains in June increased more quickly, a reflection of good economic trends despite underlying problems. Official figures revealed a 3.6% year-on-year rise in profits, against a 0.7% increase in May. Strong industry output, according to the National Bureau of Statistics (NBS), helped to explain this increase....

Continue Reading
CyberArk Marks a Decade of Growth and Innovation Since IPO

Updated Category News Views 222

CyberArk Celebrates a Decade Since Its IPO In a significant milestone, CyberArk, a leader in identity security, marks ten years since its Initial Public Offering (IPO) on the NASDAQ. This anniversary serves as a moment for reflection and highlights essential achievements throughout the company's growth. Ringing the NASDAQ Bell to Honor Their Journey On the day of the...

Continue Reading
Projected Growth of the Biosurgery Market to $21.59 Billion

Updated Category News Views 145

Biosurgery Market Overview The global biosurgery market, currently valued at approximately US$14.96 billion, is expected to grow to a remarkable US$21.59 billion by a specified target year. This substantial growth, projected at an impressive CAGR of 6.4%, is fueled primarily by the urgent need for effective management of blood loss during surgical procedures and the rise...

Continue Reading
MIND Technology, Inc. Reports Growth Amidst Market Challenges

Updated Category News Views 188

Overview of MIND Technology's Recent Performance MIND Technology, Inc. (NASDAQ: MIND) has recently unveiled its financial outcomes for the third quarter of fiscal 2026. The company achieved revenues amounting to approximately $9.7 million during this period. Comparative Revenue Analysis This figure reflects a notable decrease from the $13.6 million realized in the prior...

Continue Reading